Patents by Inventor Gregory Brooks

Gregory Brooks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080019764
    Abstract: A spring post fastening system includes a reception member including a bottom interference member and a center protrusion extending from the bottom interference member, the center protrusion defining a center reception orifice and a retention notch, and an engagement member~including a top interference member and an engagement protrusion coupled to the top interference member. The engagement protrusion includes at least one notch engagement protrusion. Further, the engagement protrusion is configured to slideably engage the reception orifice.
    Type: Application
    Filed: May 11, 2007
    Publication date: January 24, 2008
    Inventors: Glenn Jakins, Gregory Brooks
  • Publication number: 20070259000
    Abstract: Method for alleviating testicular pain in a patient in need thereof. The method can comprise the step of locally administering a neurotoxin (e.g., a botulinum toxin) to at least one anatomical site selected from the group consisting of a testicle and a tissue associated with the testicle of the patient.
    Type: Application
    Filed: May 2, 2006
    Publication date: November 8, 2007
    Applicant: ALLERGAN, INC.
    Inventor: Gregory Brooks
  • Publication number: 20070140969
    Abstract: Skin topographical methods for quantifying pharmacodynamic parameters of a paralytic effect of a Clostridial toxin, such as a botulinum toxin upon a muscle, such as a frontalis muscle. The methods are effective in determining the potency of a Clostridial toxin, and in comparing toxins. For example, wrinkle reduction effects caused by one or more neurotoxins may be monitored, and differences in effects correspond to differences of neurotoxins.
    Type: Application
    Filed: October 24, 2006
    Publication date: June 21, 2007
    Applicant: ALLERGAN, INC.
    Inventors: Lisa Hanin, Gregory Brooks
  • Publication number: 20070140968
    Abstract: Skin topographical methods for quantifying pharmacodynamic parameters of a paralytic effect of a Clostridial toxin, such as a botulinum toxin upon a muscle, such as a frontalis muscle. The methods are effective in determining the potency of a Clostridial toxin, and in comparing toxins. For example, wrinkle reduction effects caused by one or more neurotoxins may be monitored, and differences in effects correspond to differences of neurotoxins.
    Type: Application
    Filed: October 24, 2006
    Publication date: June 21, 2007
    Applicant: ALLERGAN, INC.
    Inventors: Lisa Hanin, Gregory Brooks
  • Publication number: 20070134158
    Abstract: Skin topographical methods for quantifying pharmacodynamic parameters of a paralytic effect of a Clostridial toxin, such as a botulinum toxin upon a muscle, such as a frontalis muscle. The methods are effective in determining the potency of a Clostridial toxin, and in comparing toxins. For example, wrinkle reduction effects caused by one or more neurotoxins may be monitored, and differences in effects correspond to differences of neurotoxins.
    Type: Application
    Filed: October 24, 2006
    Publication date: June 14, 2007
    Applicant: ALLERGAN, INC.
    Inventors: LISA HANIN, Gregory Brooks
  • Publication number: 20070128227
    Abstract: Methods for treating an injured muscle by local administration of a neurotoxin, such as a botulinum toxin, to promote healing and/or to reduce the pain associated with an injured muscle.
    Type: Application
    Filed: August 22, 2006
    Publication date: June 7, 2007
    Applicant: ALLERGAN, INC.
    Inventors: Gregory Brooks, Kei Aoki
  • Publication number: 20060216313
    Abstract: Methods of treating a urethral stricture in a patient. The methods can include the step of administering an therapeutically effective amount of a botulinum toxin directly to a urethra of the patient, for example by use of a stent from which the botulinum toxin can elute or diffuse, thereby treating the urethra stricture.
    Type: Application
    Filed: June 2, 2006
    Publication date: September 28, 2006
    Applicant: ALLERGAN, INC.
    Inventors: Gregory Brooks, Stephen Donovan
  • Publication number: 20060127417
    Abstract: The present invention provides for methods of treating cardiovascular diseases in a mammal. The methods include a step of administering an effective amount of a botulinum toxin directly to a blood vessel of a mammal thereby treating a cardiovascular disease.
    Type: Application
    Filed: February 1, 2006
    Publication date: June 15, 2006
    Applicant: Allergan, Inc.
    Inventors: Gregory Brooks, Stephen Donovan
  • Publication number: 20050281846
    Abstract: Methods for treating an injured muscle by local administration of a neurotoxin, such as a botulinum toxin, to promote healing and/or to reduce the pain associated with an injured muscle.
    Type: Application
    Filed: November 3, 2004
    Publication date: December 22, 2005
    Applicant: ALLERGAN, INC.
    Inventors: Gregory Brooks, Kei Aoki
  • Publication number: 20050241652
    Abstract: Skin topographical methods for quantifying pharmacodynamic parameters of a paralytic effect of a Clostridial toxin, such as a botulinum toxin upon a muscle, such as a frontalis muscle. The methods are effective in determining the potency of a Clostridial toxin, and in comparing toxins. For example, wrinkle reduction effects caused by one or more neurotoxins may be monitored, and differences in effects correspond to differences of neurotoxins.
    Type: Application
    Filed: November 24, 2004
    Publication date: November 3, 2005
    Applicant: Allergan, Inc.
    Inventors: Lisa Hanin, Gregory Brooks
  • Publication number: 20050214327
    Abstract: A botulinum toxin system for in vivo release of therapeutic amounts of botulinum toxin in a human patient over a prolonged period of time. The system may be a suppository effective in treating one or more anorectal disorders or conditions, such as anal fissures, hemorrhoids, anismus, and the like.
    Type: Application
    Filed: November 22, 2004
    Publication date: September 29, 2005
    Applicant: ALLERGAN, INC.
    Inventors: Gregory Brooks, Stephen Donovan